All stock lists
Mannkind Corp (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
Healthcare · Biotechnology
3.18-0.01 (-0.31%)
Insider Score
––Not scored
MNKD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MNKD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 109.38 M | 90.17 M | 111.95 M | 82.13 M | 76.53 M |
| Revenue Growth (YoY) | 42.92 % | — | — | — | — |
| Cost of Revenue | 29.54 M | 17.47 M | 29.67 M | 20.20 M | 20.57 M |
| Gross Profit | 79.83 M | 72.70 M | 82.28 M | 61.93 M | 55.96 M |
| SG&A Expense | 58.30 M | 54.09 M | 58.41 M | 29.09 M | 31.62 M |
| R&D Expense | 18.00 M | 17.23 M | 27.59 M | 14.06 M | 13.68 M |
| Operating Expenses | 80.67 M | 75.68 M | 89.97 M | 43.15 M | 45.30 M |
| Operating Income | -835.00 K | -2.98 M | -7.69 M | 18.78 M | 10.66 M |
| Pretax Income | -19.14 M | -16.37 M | -20.93 M | 7.78 M | 940.00 K |
| Tax Provision | -106.00 K | 253.00 K | -4.98 M | -204.00 K | 272.00 K |
| Net Income | -19.03 M | -16.62 M | -15.95 M | 7.99 M | 668.00 K |
| EPS (Basic) | -0.06 | -0.05 | -0.05 | 0.03 | 0.00 |
| EPS (Diluted) | -0.06 | -0.05 | -0.05 | 0.03 | 0.00 |
| Shares Outstanding | 309.19 M | 308.27 M | 307.26 M | 306.81 M | 304.95 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.